Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Ryan Lanning

Concepts (165)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Trastuzumab
1
2015
89
0.470
Why?
Neoplasm Recurrence, Local
2
2018
850
0.440
Why?
Receptor, ErbB-2
1
2015
300
0.410
Why?
Antineoplastic Agents
3
2019
1875
0.350
Why?
Carcinoma, Squamous Cell
3
2017
577
0.290
Why?
Laryngeal Neoplasms
2
2017
27
0.280
Why?
Microscopy
2
2022
125
0.260
Why?
Breast Neoplasms
3
2015
1846
0.260
Why?
Carcinoma
2
2017
198
0.240
Why?
Neoplasms
6
2022
2086
0.220
Why?
Head and Neck Neoplasms
2
2017
427
0.190
Why?
Glottis
2
2017
13
0.180
Why?
Mammary Neoplasms, Experimental
2
2019
64
0.180
Why?
Drug Carriers
1
2019
112
0.150
Why?
Chemoradiotherapy
2
2017
187
0.150
Why?
Oxygen
4
2022
851
0.150
Why?
Radiotherapy, Adjuvant
2
2017
182
0.150
Why?
Cisplatin
1
2019
262
0.150
Why?
Chemotherapy, Adjuvant
2
2017
332
0.140
Why?
Nasopharyngeal Neoplasms
1
2017
13
0.140
Why?
Meningioma
1
2018
76
0.140
Why?
Carcinoma, Adenosquamous
1
2017
9
0.140
Why?
Carcinoma, Mucoepidermoid
1
2017
15
0.140
Why?
Meningeal Neoplasms
1
2018
86
0.140
Why?
Nose Neoplasms
1
2017
14
0.140
Why?
Paranasal Sinus Neoplasms
1
2017
16
0.140
Why?
Dexamethasone
1
2019
316
0.140
Why?
Carcinoma, Adenoid Cystic
1
2017
16
0.140
Why?
Ear Neoplasms
1
2016
4
0.140
Why?
Ear Canal
1
2016
14
0.130
Why?
Rhabdomyosarcoma, Embryonal
1
2016
17
0.130
Why?
Misonidazole
1
2016
1
0.130
Why?
Radiotherapy, Image-Guided
1
2016
30
0.130
Why?
Oropharyngeal Neoplasms
1
2016
39
0.130
Why?
Radiotherapy Planning, Computer-Assisted
1
2016
117
0.130
Why?
Brachytherapy
1
2016
100
0.130
Why?
Nanoparticles
1
2019
312
0.120
Why?
Radiotherapy, Intensity-Modulated
1
2016
124
0.120
Why?
Mastectomy
1
2015
99
0.120
Why?
Lymphatic Metastasis
1
2015
275
0.110
Why?
Quantum Dots
1
2013
34
0.110
Why?
Protein Array Analysis
1
2013
55
0.110
Why?
Disease-Free Survival
1
2015
618
0.110
Why?
Aged
8
2018
18971
0.100
Why?
Optics and Photonics
2
2003
41
0.100
Why?
Propensity Score
3
2017
225
0.100
Why?
Middle Aged
9
2018
26607
0.090
Why?
Neoplasm Metastasis
3
2019
521
0.090
Why?
Melanoma
1
2017
620
0.090
Why?
Spectroscopy, Near-Infrared
2
2002
47
0.090
Why?
Aged, 80 and over
3
2017
6307
0.090
Why?
Proportional Hazards Models
3
2017
1078
0.080
Why?
Female
15
2019
59326
0.080
Why?
Fluorescence Recovery After Photobleaching
1
2009
18
0.080
Why?
Cell Physiological Phenomena
1
2009
23
0.080
Why?
Extracellular Fluid
1
2009
30
0.080
Why?
Palliative Care
1
2015
641
0.080
Why?
Glucose
1
2013
899
0.080
Why?
Young Adult
4
2017
10446
0.080
Why?
Tumor Microenvironment
2
2022
428
0.070
Why?
Adult
7
2018
30377
0.070
Why?
Diagnostic Imaging
1
2009
278
0.070
Why?
Blood Vessels
1
2007
179
0.060
Why?
Imaging, Three-Dimensional
1
2009
511
0.060
Why?
Fetal Blood
1
2007
268
0.060
Why?
Radiotherapy Dosage
2
2016
243
0.060
Why?
Kaplan-Meier Estimate
2
2017
813
0.060
Why?
Hematopoietic Stem Cells
1
2007
338
0.060
Why?
Humans
16
2018
114049
0.060
Why?
Multivariate Analysis
2
2017
1422
0.050
Why?
Survival Rate
2
2017
1638
0.050
Why?
Spectrophotometry
1
2002
47
0.050
Why?
Angiotensins
1
2022
10
0.050
Why?
Receptors, Angiotensin
1
2022
9
0.050
Why?
Losartan
1
2022
9
0.050
Why?
Endothelial Cells
1
2007
677
0.050
Why?
Mice
5
2022
14843
0.050
Why?
Databases, Factual
2
2017
1125
0.050
Why?
Magnetic Resonance Imaging
2
2003
3039
0.050
Why?
Animals
8
2022
31565
0.050
Why?
Time Factors
5
2017
6077
0.050
Why?
Mammography
1
2002
101
0.050
Why?
Neoplasm Transplantation
3
2009
227
0.050
Why?
Male
8
2018
55398
0.040
Why?
Diffusion
2
2011
119
0.040
Why?
Photons
1
2000
57
0.040
Why?
Micelles
1
2019
34
0.040
Why?
Cohort Studies
2
2018
4883
0.040
Why?
Mice, Nude
1
2019
628
0.040
Why?
Margins of Excision
1
2017
29
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2017
40
0.030
Why?
Otorhinolaryngologic Surgical Procedures
1
2017
33
0.030
Why?
United States
3
2017
12137
0.030
Why?
Adenocarcinoma
1
2003
787
0.030
Why?
Organs at Risk
1
2016
30
0.030
Why?
Mice, Inbred BALB C
1
2019
1144
0.030
Why?
Tumor Hypoxia
1
2016
5
0.030
Why?
Radiometry
1
2016
41
0.030
Why?
Radiotherapy, Conformal
1
2016
68
0.030
Why?
Hypoxia
1
2022
956
0.030
Why?
Skin Neoplasms
1
2003
754
0.030
Why?
Radiation Protection
1
2016
34
0.030
Why?
Radiopharmaceuticals
1
2016
158
0.030
Why?
Insurance Coverage
1
2017
199
0.030
Why?
Cochlea
1
2016
90
0.030
Why?
Combined Modality Therapy
1
2018
1117
0.030
Why?
Neoadjuvant Therapy
1
2017
305
0.030
Why?
Positron-Emission Tomography
1
2016
260
0.030
Why?
Lymph Nodes
1
2017
415
0.030
Why?
Infant
2
2017
7944
0.030
Why?
Treatment Outcome
2
2018
9049
0.030
Why?
Neoplasm Staging
1
2017
1162
0.030
Why?
Boronic Acids
1
2013
33
0.030
Why?
Rats
3
2009
4913
0.030
Why?
Socioeconomic Factors
1
2017
1080
0.030
Why?
Cell Line, Tumor
1
2019
2700
0.030
Why?
Rats, Inbred F344
2
2003
241
0.030
Why?
Hydrogen-Ion Concentration
1
2013
507
0.020
Why?
Logistic Models
1
2017
1829
0.020
Why?
Fluorescent Dyes
1
2013
298
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
1356
0.020
Why?
Disease Progression
1
2018
2371
0.020
Why?
Retrospective Studies
2
2018
12521
0.020
Why?
Health Services Accessibility
1
2017
756
0.020
Why?
Drug Delivery Systems
1
2013
295
0.020
Why?
Scattering, Radiation
2
2002
94
0.020
Why?
Lymphography
1
2009
6
0.020
Why?
Subcutaneous Tissue
1
2009
17
0.020
Why?
Prognosis
1
2017
3315
0.020
Why?
Fluorescein Angiography
1
2009
104
0.020
Why?
Transplantation, Heterologous
1
2009
180
0.020
Why?
Adolescent
2
2017
17802
0.020
Why?
Microvessels
1
2009
66
0.020
Why?
Chickens
1
2009
180
0.020
Why?
Mice, Mutant Strains
1
2009
271
0.020
Why?
Collagen Type I
1
2009
108
0.020
Why?
Image Enhancement
1
2009
158
0.020
Why?
Equipment Design
1
2009
503
0.020
Why?
Hyaluronic Acid
1
2009
189
0.020
Why?
Cell Membrane Permeability
1
2007
83
0.020
Why?
Tomography, X-Ray Computed
1
2016
2272
0.020
Why?
Glioblastoma
1
2009
250
0.020
Why?
Cell Separation
1
2007
290
0.020
Why?
Infant, Newborn
1
2017
5038
0.020
Why?
Prospective Studies
1
2017
6195
0.020
Why?
Disease Models, Animal
1
2013
3498
0.010
Why?
Child, Preschool
1
2017
9115
0.010
Why?
Indocyanine Green
1
2002
12
0.010
Why?
Methylene Blue
1
2002
22
0.010
Why?
Coloring Agents
1
2002
72
0.010
Why?
Algorithms
1
2009
1469
0.010
Why?
Fibroadenoma
1
2002
2
0.010
Why?
Cell Line
1
2007
2629
0.010
Why?
Premenopause
1
2002
105
0.010
Why?
Breast
1
2002
138
0.010
Why?
Cell Proliferation
1
2007
2173
0.010
Why?
Radiography
1
2002
803
0.010
Why?
Contrast Media
1
2002
347
0.010
Why?
Enzyme Inhibitors
1
2002
743
0.010
Why?
Kinetics
1
2002
1547
0.010
Why?
Lipid Metabolism
1
2002
441
0.010
Why?
Water
1
2002
394
0.010
Why?
Child
1
2017
18404
0.010
Why?
Models, Theoretical
1
2002
513
0.010
Why?
Hemoglobins
1
2000
308
0.010
Why?
Lanning's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)